Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
- Behavioral Pharmacological Examination of a Novel Buprenorphine Induction Method Among Individuals Who Use Fentanyl
- Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder
- Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder
- Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion
- Novel Induction to Buprenorphine/Naloxone
- Monthly Versus Daily Buprenorphine Formulations for Treatment of Opiate Use Disorder
- Medication-assisted Treatment for Injecting Drug Users in Vietnam
- Olanzapine in OUD Patients
- Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl
- Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
- Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSP
- Cariprazine for Comorbid Cocaine and Opioid Use Didorder
- A Study to Assess the Safety and Efficacy of ASP8062 as an Add-on Therapy to Buprenorphine/Naloxone in Participants With Opioid Use Disorder
- Assessing a Clinically-meaningful Opioid Withdrawal Phenotype
- Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
- Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments
- Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use Disorder
- Buprenorphine Induction for Fentanyl Dependent Opioid Users
- Buprenorphine/Naloxone Micro-Dosing for Postoperative Pain Management in Opioid-Tolerant Patients
- Virginia Opioid Treatment-Emergency Department
- Providing Suboxone and PrEP Using Telemedicine
- Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
- A Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Participants With Opioid Use Disorder
- Buprenorphine Loading in the Emergency Department
- Comparing Rapid Micro-Induction and Standard Induction of Buprenorphine/Naloxone for Treatment of Opioid Use Disorder
- Long-acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-involved Adults
- Combining Pregabalin (LYRICA®) With Lofexidine (LUCEMYRATM) to Treat OPIOID Withdrawal
- Long Acting Subcutaneous vs Short Acting Sublingual Buprenorphine in Pregnant and Lactating Women
- Adjunctive Effects of Psilocybin and Buprenorphine
- A Prospective, Randomized Trial of the Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms
- Oxytocin, Stress, Craving, Opioid Use Disorder
- Rapid Initiation of Drug Treatment Engagement
- Community Studies of Long Acting Buprenorphine (CoLAB)
- Cannabidiol as Adjunctive Treatment for Opioid Use Disorder
- Long Acting Buprenorphine Injection Compared to Sublingual Buprenorphine/Naloxone Films
- Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology
- Comparison of Three Opioid Detoxification Treatment Regimens
- Long Acting Naltrexone for Opioid Addiction: Focus on Sustained Abstinence and Recovery
- Optimal Treatment of Veterans With PTSD and Comorbid OUD
- XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of Concept
- Improving Office Based Treatment of Opioid Use Disorder With Technology
- Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy
- Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal
- Maternal Buprenorphine-naloxone Treatment and the Infant
- Effect of Buprenorphine/Naloxone Continuation on Pain Control and Opioid Use
- A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic
- Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings
- A Pragmatic Randomized Control Trial Comparing Models of Care in the Management of Prescription Opioid Misuse
- Veterans' Pain Care Organizational Improvement Comparative Effectiveness Study
- Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence
- A Study to Assess the Drug-drug Interaction of BMS 663068 With Methadone and Also With Buprenorphine/Naloxone
- The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent Subjects
- Comparing Opium Tincture (OT) With Methadone for Medication-assisted Treatment of Opioid Use Disorder
- Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers
- Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine
- Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone
- A Study of Adult Outpatients With Opioid Dependence Transitioned From a Daily SL Buprenorphine to Probuphine® Subdermal Implants
- Analgesic Response to Opioid Analgesics in Buprenorphine-Maintained Individuals
- Drug Interaction & Methadone & Buprenorphine
- Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent Population
- Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment
- Prescription Opioid Abuse Among Pain Patients: Predictors of Relapse
- Buprenorphine to Improve HIV Care Engagement and Outcomes
- An Open-label, Single Arm, Phase 2 Study to Evaluate ABT-450/r/ABT-267 and ABT-333 With Ribavirin (RBV) in Adults With Genotype 1 HCV Infection Taking Methadone or Buprenorphine
- Efficacy of BNX Sublingual Tablets Versus BNX Sublingual Film for Treatment of Opioid-Dependent Adults
- Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
- Improving Buprenorphine Detoxification Outcomes With Isradipine
- Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain
- Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence
- Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects
- Dane County Drug Court Study for Addicted Offenders
- Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients
- Pharmacokinetic & Pharmacodynamic Interaction of Lofexidine and Buprenorphine in Buprenorphine Maintained Patients
- Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone
- Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in Norway
- Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence
- An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
- Drug Interaction Study With BI 201335 and Methadone or Buprenorphine/Naloxone
- Buprenorphine and Methadone for Opioid-dependent Chronic Back Pain Patients
- Pioglitazone to Treat Opioid Withdrawal Symptoms
- Effects of Voriconazole on the Pharmacokinetics and Pharmacodynamics of Oral Buprenorphine: A Two-phase Cross-over Study in Healthy Subjects
- Cocaine Use Reduction With Buprenorphine
- A Study to Evaluate the Pharmacokinetic Effect of SCH 503034 (Boceprevir) on Methadone or Buprenorphine/Naloxone Plasma Concentrations (P08123)
- Improved Strategies for Outpatient Opioid Detoxification
- Effects of Posaconazole and Voriconazole on the Pharmacokinetics and Pharmacodynamics of Sublingual Buprenorphine
- Drug-Drug Interaction Study Between Telaprevir and Buprenorphine
- Study to Assess the PK Profile of NanoBUP Capsules Relative to Suboxone
- A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals
- Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents
- Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France ("RIME")
- Disulfiram for Cocaine Abuse in Buprenorphine Treatment
- Multicentre Trial of Suboxone in Opiate-dependent Subjects in Taiwan
- A Single-Dose Study of an Investigational Capsule Formulation of 2 mg/0.5 mg Buprenorphine/Naloxone
- Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications
- TMC125-TiDP2-C188: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Effect of Multiple-dose TMC125 on Buprenorphine and Norbuprenorphine Administered in HIV-negative Patients on Stable Buprenorphine/Naloxone Maintenance Therapy.
- Buprenorphine Naltrexone-P1 A-Cocaine
- Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444)
- Treatment of Opioid Dependent Patients With Suboxone: Acceptability & Safety Data From Real Life Scenario (Study P05603)
- Abuse Liability of Suboxone Versus Subutex
- Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED)
- Randomized, Double-Blind Cross-Over Trial Of Buprenorphine and Low-Dose Naloxone Versus Buprenorphine
- Safety and Tolerability of Buprenorphine/Naloxone Film Strips
- Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone
- Buprenorphine as a Treatment in Opiate Dependent Pain Patients
- Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir
- Starting Treatment With Agonist Replacement Therapies (START)
- Drug Treatment Combined With Drug and Risk Reduction Counseling to Prevent of HIV Infection and Death Among Injection Drug Users
- Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1
- Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1
- Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users
- Abuse Potential of Buprenorphine/Naloxone
- Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence
- Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
- Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers
- Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1
- Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1
- Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1
- Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1
- Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14
- Buprenorphine and Naloxone Combination Study - 10
- Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1
- Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1
- Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice
- Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
- Trial of Buprenorphine/Naloxone for Opiate Dependence - 2
- Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1
- Buprenorphine Combination Tablet Feasibility - 1
- Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone
Clinical trials list
click for details